Antibody data
- Antibody Data
- Antigen structure
- References [5]
- Comments [0]
- Validations [0]
Submit
Validation data
Reference
Comment
Report error
- Product number
- ABIN395210 - Provider product page
- Provider
- antibodies-online
- Product name
- anti-Kallikrein 10 (KLK10) antibody
- Antibody type
- Monoclonal
- Antigen
- KLK10 (NP_002767, 167 a.a. ~ 277 a.a) partial recombinant protein with GST tag. MW of the GST tag alone is 26 K
- Description
- Purified
- Reactivity
- Human
- Host
- Mouse
- Isotype
- IgG
- Antibody clone number
- 1G8
- Vial size
- 0.05 mg
- Concentration
- 1 mg/ml
- Storage
- Maintain refrigerated at 2-8°C for up to 6 months. For long term storage store at -20°C in small aliquots to prevent freeze-thaw cycles
Submitted references Blood biomarker levels to aid discovery of cancer-related single-nucleotide polymorphisms: kallikreins and prostate cancer.
Kallikrein-related peptidase 10 (KLK10) expression and single nucleotide polymorphisms in ovarian cancer survival.
Smad signaling is required to maintain epigenetic silencing during breast cancer progression.
The kallikrein family of proteins as urinary biomarkers for the detection of prostate cancer.
Aberrant DNA methylation profile and frequent methylation of KLK10 and OXGR1 genes in hepatocellular carcinoma.
Klein RJ, Halldén C, Cronin AM, Ploner A, Wiklund F, Bjartell AS, Stattin P, Xu J, Scardino PT, Offit K, Vickers AJ, Grönberg H, Lilja H
Cancer prevention research (Philadelphia, Pa.) 2010 May;3(5):611-9
Cancer prevention research (Philadelphia, Pa.) 2010 May;3(5):611-9
Kallikrein-related peptidase 10 (KLK10) expression and single nucleotide polymorphisms in ovarian cancer survival.
Batra J, Tan OL, O'Mara T, Zammit R, Nagle CM, Clements JA, Kedda MA, Spurdle AB
International journal of gynecological cancer : official journal of the International Gynecological Cancer Society 2010 May;20(4):529-36
International journal of gynecological cancer : official journal of the International Gynecological Cancer Society 2010 May;20(4):529-36
Smad signaling is required to maintain epigenetic silencing during breast cancer progression.
Papageorgis P, Lambert AW, Ozturk S, Gao F, Pan H, Manne U, Alekseyev YO, Thiagalingam A, Abdolmaleky HM, Lenburg M, Thiagalingam S
Cancer research 2010 Feb 1;70(3):968-78
Cancer research 2010 Feb 1;70(3):968-78
The kallikrein family of proteins as urinary biomarkers for the detection of prostate cancer.
Sardana G, Diamandis EP
Clinical biochemistry 2009 Sep;42(13-14):1483-6
Clinical biochemistry 2009 Sep;42(13-14):1483-6
Aberrant DNA methylation profile and frequent methylation of KLK10 and OXGR1 genes in hepatocellular carcinoma.
Lu CY, Hsieh SY, Lu YJ, Wu CS, Chen LC, Lo SJ, Wu CT, Chou MY, Huang TH, Chang YS
Genes, chromosomes & cancer 2009 Dec;48(12):1057-68
Genes, chromosomes & cancer 2009 Dec;48(12):1057-68
No comments: Submit comment
No validations: Submit validation data